Overall rank by patents
#13,513
of 50,000 tracked assignees
USPTO PatentsView assignee record - 22 granted patents across 11 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
According to USPTO PatentsView, Joslin ranks #13,513 of 50,000 tracked US assignees by granted-patent volume, with 22 patents across 11 technology areas.
USPTO PatentsView assignee plate
Corpus R13513 · US Corporation #13,513 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Jewelex New York, Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Joslin Diabetes Center · this assignee
37 score
3D Lighting Innovati… · lowest
7 score
What this shows Joslin Diabetes Center stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-PAR, TYPE-USCORP, VEL-FLAT, BOOK-FULL. Volume places it #13,513 of 50,000; Innovation Score 37.0/100 sits in the top 45% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Jewelex New York, Ltd. (±0 grants).
Joslin Diabetes Center has been granted 22 US utility patents between 2015 and 2024, placing Joslin Diabetes Center at #13,513 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Joslin Diabetes Center is one of the more focused assignees in the PatentsView dataset. By volume, Joslin sits between Jewelex New York, Ltd. (22 patents, rank #13,507) and Kromek Limited (22 patents, rank #13,515) - the closest US assignees by grant volume. The composite Innovation Score of 37.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 11 grants, compared with 11 in the 2015–2019 window, a +0% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Joslin Diabetes Center's 8.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 11 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Jewelex New York, Ltd.
22 patents
Jichi Medical University
22 patents
Johnson Controls Light Commercial IP GmbH
22 patents
Johnson Matthey Catalysts (Germany) GmbH
22 patents
KCC Corporation
22 patents
KIEFEL GMBH
22 patents
KNORR-BREMSE GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG
22 patents
KROMEK LIMITED
22 patents
Joslin Diabetes Center
22 patents
What this shows Joslin holds 22 patents at rank #13,511, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,511 in granted patent volume.
Other assignees with the most granted patents in Joslin's primary technology class.
Joslin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 45% higher than 55% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 4.5% |
| 2016 | 4 | 18.2% |
| 2017 | 3 | 13.6% |
| 2018 | 2 | 9.1% |
| 2019 | 1 | 4.5% |
| 2020 | 2 | 9.1% |
| 2021 | 2 | 9.1% |
| 2022 | 2 | 9.1% |
| 2023 | 1 | 4.5% |
| 2024 | 4 | 18.2% |
Top 11 of 11 technology areas
Overall rank by patents
#13,513
of 50,000 tracked assignees
37.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.